Erratum to "Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease" [J Prev Alzheimers Dis 2025;12(4): 100082] [0.03%]
“沙比瑞单抗（ACU193）治疗早期阿尔茨海默病患者后的生物流体生物标志物变化：INTERCEPT-AD一期试验的撤回声明”[J Prev Alzheimers Dis 2025;12(4): 100082]的勘误表
Erika N Cline,Daniel Antwi-Berko,Karen Sundell et al.
Erika N Cline et al.
Mass spectrometry-based methods for biofluid biomarkers for progressive diseases: amyloid peptides and dystrophins [0.03%]
基于质谱的生物体液生物标志物检测方法在进行性疾病的诊断和治疗中的应用：以淀粉样蛋白肽和肌萎缩蛋白为例研究
Makoto Niwa,Kenta Noda,Yoshiyuki Kobayashi et al.
Makoto Niwa et al.
Purpose: Using two diseases, Alzheimer's disease and muscular dystrophy as examples, in which many resources have been invested, trends in bioanalytical techniques for detection of peptide or protein biomarkers using mass...
Mari Aksnes
Mari Aksnes
Background: Alzheimer's disease (AD), the most common cause of dementia, affects twice as many women as men. Moreover, sex is increasingly recognised as an important factor for AD, influencing symptom presentation, progre...
Novel metabolomics-biohumoral biomarkers model for predicting survival of metastatic soft-tissue sarcomas [0.03%]
用于预测转移性软组织肉瘤生存的新代谢组学-生物体液生物标志物模型
Alessia Vignoli,Gianmaria Miolo,Leonardo Tenori et al.
Alessia Vignoli et al.
Soft tissue sarcomas (STSs) are rare malignant tumors that are difficult to prognosticate using currently available instruments. Omics sciences could provide more accurate and individualized survival predictions for patients with metastatic...
DNA photoproducts released by repair in biological fluids as biomarkers of the genotoxicity of UV radiation [0.03%]
DNA光产物作为UV辐射遗传毒性的生物标志物及其在生物液体中的修复释放作用研究
Noémie Reynaud,Laura Belz,David Béal et al.
Noémie Reynaud et al.
UV-induced formation of photoproducts in DNA is a major initiating event of skin cancer. Consequently, many analytical tools have been developed for their quantification in DNA. In the present work, we extended our previous liquid chromatog...
Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain [0.03%]
多中心评估运动神经元病生物标志物显示血轻链神经丝蛋白为主要指标
Alexander G Thompson,Elizabeth Gray,Nick Verber et al.
Alexander G Thompson et al.
The routine clinical integration of individualized objective markers of disease activity in those diagnosed with the neurodegenerative disorder amyotrophic lateral sclerosis is a key requirement for therapeutic development. A large, multice...
Biofluid-based biomarkers for Alzheimer's disease-related pathologies: An update and synthesis of the literature [0.03%]
阿尔茨海默病相关病理的生物液体标志物：文献更新及综述
Henrik Zetterberg
Henrik Zetterberg
The past few years have seen an explosion in sensitive and specific assays for cerebrospinal fluid (CSF) and blood biomarkers for Alzheimer's disease (AD) and related disorders, as well as some novel assays based on pathological seed-induce...
Raman, Infrared and Brillouin Spectroscopies of Biofluids for Medical Diagnostics and for Detection of Biomarkers [0.03%]
用于医学诊断和检测生物标志物的生物流体拉曼、红外和布里渊光谱学
Sultan Aitekenov,Alisher Sultangaziyev,Perizat Abdirova et al.
Sultan Aitekenov et al.
This review surveys Infrared, Raman/SERS and Brillouin spectroscopies for medical diagnostics and detection of biomarkers in biofluids, that include urine, blood, saliva and other biofluids. These optical sensing techniques are non-contact,...
Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias [0.03%]
蛋白质组学方法发现神经退行性痴呆生物流体生物标志物的研究
Becky C Carlyle,Bianca A Trombetta,Steven E Arnold
Becky C Carlyle
Neurodegenerative dementias are highly complex disorders driven by vicious cycles of intersecting pathophysiologies. While most can be definitively diagnosed by the presence of disease-specific pathology in the brain at postmortem examinati...
耗时 0.26486 秒，为您在
48223910
条记录里面共找到 16 篇文章 [XML]